🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary objective: * To demonstrate that 3 doses of a vaccine containing T...
Status
Completed
Location
Sanofi Pasteur MSD investigational site
Start Date
2011-01
Trial ID
NCT01287949
Treatments Being Tested
This is a study to assess the safety, tolerability, and immunogenicity of V...
Status
Completed
Location
Multiple Locations
Start Date
2011-04-19
Trial ID
NCT01337167
Treatments Being Tested
In July 2015-November 2016, a phase II/III randomized, observer-blind,contr...
Status
Completed
Location
Vaccine Trial Centre, Faculty of Tropical Medicine, Mhahidol University, 420/6 Ratchawithi Road, Ratchathewi,
Start Date
2018-06-26
Trial ID
NCT04102137
Treatments Being Tested
Objectives: * To present the rates of adverse reactions after a dose of DA...
Status
Completed
Location
Multiple Locations
Start Date
2004-02
Trial ID
NCT00802867
Treatments Being Tested
This study is designed to evaluate the safety and immunogenicity of new for...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-12-09
Trial ID
NCT01248884
Treatments Being Tested
The present clinical study will assess the immunogenicity and reactogenicit...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT00319852
Treatments Being Tested
This is a global Phase 3 study to evaluate the safety and effectiveness of ...
Status
Completed
Location
The University of Alabama at Birmingham Hosptial Outreach Lab
Start Date
2019-07-18
Trial ID
NCT04006457
The purpose of this study is to assess the immunogenicity and safety of the...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-09-19
Trial ID
NCT02853929
Treatments Being Tested
The aims of this trial are to demonstrate the consistency of three manufact...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-01-06
Trial ID
NCT00148941
Treatments Being Tested
The primary immunogenicity objective is to assess and compare the immunogen...
Status
Completed
Location
Site 22
Start Date
2008-03
Trial ID
NCT00667602
Treatments Being Tested